Hematopoietic stem cell gene therapy for adenosine deaminase deficient-SCID

被引:23
|
作者
Aiuti, Alessandro [1 ,2 ,3 ]
Brigida, Immacolata [1 ,2 ]
Ferrua, Francesca [1 ,2 ]
Cappelli, Barbara [1 ,2 ]
Chiesa, Robert [1 ,2 ]
Marktel, Sarah [1 ,2 ]
Roncarolo, Maria-Grazia [1 ,2 ,4 ]
机构
[1] Sci Inst HS Raffaele, San Raffaele Telethon Inst Gene Therapy HSR TIGET, I-20132 Milan, Italy
[2] Sci Inst HS Raffaele, Pediat Immunohematol & Bone Marrow Transplant Uni, I-20132 Milan, Italy
[3] Univ Roma Tor Vergata, Rome, Italy
[4] Univ Vita Salute, Milan, Italy
关键词
Gene therapy; Hematopoietic stem cell; Bone marrow; Severe combined immunodeficiency; Retroviral vector; SEVERE COMBINED IMMUNODEFICIENCY; BONE-MARROW-TRANSPLANTATION; INSERTIONAL MUTAGENESIS; CD34(+) CELLS; CORD BLOOD; IMMUNE RECONSTITUTION; LENTIVIRAL VECTORS; MOUSE MODEL; ADA; LYMPHOCYTES;
D O I
10.1007/s12026-009-8107-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Gene therapy is a highly attractive strategy for many types of inherited disorders of the immune system. Adenosine deaminase (ADA) deficient-severe combined immunodeficiency (SCID) has been the target of several clinical trials based on the use of hematopoietic stem/progenitor cells engineered with retroviral vectors. The introduction of a low intensity conditioning regimen has been a crucial factor in achieving stable engrafment of hematopoietic stem cells and therapeutic levels of ADA-expressing cells. Recent studies have demonstrated that gene therapy for ADA-SCID has favorable safety profile and is effective in restoring normal purine metabolism and immune functions. Stem cell gene therapy combined with appropriate conditioning regimens might be extended to other genetic disorders of the hematopoietic system.
引用
收藏
页码:150 / 159
页数:10
相关论文
共 50 条
  • [41] Autologous Ex Vivo Lentiviral Gene Therapy for Adenosine Deaminase Deficiency
    Kohn, D. B.
    Booth, C.
    Shaw, K. L.
    Xu-Bayford, J.
    Garabedian, E.
    Trevisan, V.
    Carbonaro-Sarracino, D. A.
    Soni, K.
    Terrazas, D.
    Snell, K.
    Ikeda, A.
    Leon-Rico, D.
    Moore, T. B.
    Buckland, K. F.
    Shah, A. J.
    Gilmour, K. C.
    De Oliveira, S.
    Rivat, C.
    Crooks, G. M.
    Izotova, N.
    Tse, J.
    Adams, S.
    Shupien, S.
    Ricketts, H.
    Davila, A.
    Uzowuru, C.
    Icreverzi, A.
    Barman, P.
    Fernandez, B. Campo
    Hollis, R. P.
    Coronel, M.
    Yu, A.
    Chun, K. M.
    Casas, C. E.
    Zhang, R.
    Arduini, S.
    Lynn, F.
    Kudari, M.
    Spezzi, A.
    Zahn, M.
    Heimke, R.
    Labik, I.
    Parrott, R.
    Buckley, R. H.
    Reeves, L.
    Cornetta, K.
    Sokolic, R.
    Hershfield, M.
    Schmidt, M.
    Candotti, F.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (21) : 2002 - 2013
  • [42] Gene therapy for adenosine deaminase-deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plans
    Candotti, Fabio
    Shaw, Kit L.
    Muul, Linda
    Carbonaro, Denise
    Sokolic, Robert
    Choi, Christopher
    Schurman, Shepherd H.
    Garabedian, Elizabeth
    Kesserwan, Chimene
    Jagadeesh, G. Jayashree
    Fu, Pei-Yu
    Gschweng, Eric
    Cooper, Aaron
    Tisdale, John F.
    Weinberg, Kenneth I.
    Crooks, Gay M.
    Kapoor, Neena
    Shah, Ami
    Abdel-Azim, Hisham
    Yu, Xiao-Jin
    Smogorzewska, Monika
    Wayne, Alan S.
    Rosenblatt, Howard M.
    Davis, Carla M.
    Hanson, Celine
    Rishi, Radha G.
    Wang, Xiaoyan
    Gjertson, David
    Yang, Otto O.
    Balamurugan, Arumugam
    Bauer, Gerhard
    Ireland, Joanna A.
    Engel, Barbara C.
    Podsakoff, Gregory M.
    Hershfield, Michael S.
    Blaese, R. Michael
    Parkman, Robertson
    Kohn, Donald B.
    BLOOD, 2012, 120 (18) : 3635 - 3646
  • [43] Lentiviral Gene Therapy for Artemis-Deficient SCID
    Cowan, Morton J. J.
    Yu, Jason
    Facchino, Janelle
    Fraser-Browne, Carol
    Sanford, Ukina
    Kawahara, Misako
    Dara, Jasmeen
    Long-Boyle, Janel
    Oh, Jess
    Chan, Wendy
    Chag, Shivali
    Broderick, Lori
    Chellapandian, Deepak
    Decaluwe, Helene
    Golski, Catherine
    Hu, Diana
    Kuo, Caroline Y. Y.
    Miller, Holly K. K.
    Petrovic, Aleksandra
    Currier, Robert
    Hilton, Joan F. F.
    Punwani, Divya
    Dvorak, Christopher C. C.
    Malech, Harry L. L.
    McIvor, R. Scott
    Puck, Jennifer M. M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (25) : 2344 - 2355
  • [44] Fetal stem cell and gene therapy
    Witt, Russell
    MacKenzie, Tippi C.
    Peranteau, William H.
    SEMINARS IN FETAL & NEONATAL MEDICINE, 2017, 22 (06) : 410 - 414
  • [45] Enrichment of Human Hematopoietic Stem/Progenitor Cells Facilitates Transduction for Stem Cell Gene Therapy
    Baldwin, Kismet
    Urbinati, Fabrizia
    Romero, Zulema
    Campo-Fernandez, Beatriz
    Kaufman, Michael L.
    Cooper, Aaron R.
    Masiuk, Katelyn
    Hollis, Roger P.
    Kohn, Donald B.
    STEM CELLS, 2015, 33 (05) : 1532 - 1542
  • [46] Busulfan Pharmacokinetics in Adenosine Deaminase-Deficient Severe Combined Immunodeficiency Gene Therapy
    Bradford, Kathryn L.
    Liu, Siyu
    Krajinovic, Maja
    Ansari, Marc
    Garabedian, Elizabeth
    Tse, John
    Wang, Xiaoyan
    Shaw, Kit L.
    Gaspar, H. Bobby
    Candotti, Fabio
    Kohn, Donald B.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (10) : 1819 - 1827
  • [47] Cell and Gene Therapy for Anemia: Hematopoietic Stem Cells and Gene Editing
    Anurogo, Dito
    Budi, Nova Yuli Prasetyo
    Mai-Huong Thi Ngo
    Huang, Yen-Hua
    Pawitan, Jeanne Adiwinata
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (12)
  • [48] Clinical Impact of Suicide Gene Therapy in Allogeneic Hematopoietic Stem Cell Transplantation
    Lupo-Stanghellini, Maria Teresa
    Provasi, Elena
    Bondanza, Attilio
    Ciceri, Fabio
    Bordignon, Claudio
    Bonini, Chiara
    HUMAN GENE THERAPY, 2010, 21 (03) : 241 - 250
  • [49] A Possible Approach for Stem Cell Gene Therapy of Fanconi Anemia
    Song, Liting
    CURRENT GENE THERAPY, 2009, 9 (01) : 26 - 32
  • [50] Morbidity in an adenosine deaminase-deficient patient during 27 years of enzyme replacement therapy
    Grunebaum, Eyal
    Reid, Brenda
    Naqvi, Ahmed
    Hershfield, Michael S.
    Kim, Vy Hong-Diep
    Muller, Matthew P.
    Hicks, Lisa K.
    Lee, Erika
    Betschel, Stephen
    Roifman, Chaim M.
    CLINICAL IMMUNOLOGY, 2020, 211